Durable Medical Equipment Market Size to Hit $291.52 Billion, Globally, by 2027 - Exclusive Report by The Insight Partners
20 sept. 2023 10h29 HE
|
The Insight Partners
Pune, India, Sept. 20, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Durable Medical Equipment Market Forecast to 2027 – Global Analysis – by Device Type (Personal Mobility Devices...
Nemaura Medical Announces Participation at HLTH 2023, Las Vegas
12 sept. 2023 09h26 HE
|
Nemaura Medical, Inc
LOUGHBOROUGH, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc.(NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercialising non-invasive...
Nemaura Medical Announces SFDA Approval of sugarBEAT®
17 août 2023 08h30 HE
|
Nemaura Medical, Inc
Loughborough, England, Aug. 17, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing a...
Nemaura Medical Secures $6.5m in Non-Dilutive Funding
11 août 2023 16h05 HE
|
Nemaura Medical, Inc
Loughborough, England, Aug. 11, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on commercializing a daily disposable wearable glucose sensor and...
Nemaura Medical to Participate at the Collision Conference in Toronto June 26-29, 2023
22 juin 2023 08h00 HE
|
Nemaura Medical, Inc
LOUGHBOROUGH, June 22, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company focused on non-invasive wearable sensors and personalized weight...
Continuous Glucose Monitoring Devices Market Size & Share to Surpass $13.24 Bn by 2028 | Vantage Market Research
09 mars 2023 05h25 HE
|
Vantage Market Research
WASHINGTON, March 09, 2023 (GLOBE NEWSWIRE) -- The global Continuous Glucose Monitoring Devices Market is expected to grow at a significant rate over the next few years due to increasing prevalence...
Nemaura Commences Pilot Program of Miboko with the NHS in the United Kingdom
29 nov. 2022 08h00 HE
|
Nemaura Medical, Inc
LOUGHBOROUGH, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive...
GLUCOTRACK ANNOUNCES THE HIRING OF DR. MARK TAPSAK
14 oct. 2022 09h45 HE
|
GlucoTrack, Inc.
INDUSTRY VETERAN TO LEAD NEW CONTINUOUS GLUCOSE MONITORING R&D PROGRAM Rutherford, NJ, Oct. 14, 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a...
GLUCOTRACK ANNOUNCES THE HIRING OF DR. MARK TAPSAK
14 oct. 2022 09h30 HE
|
GlucoTrack, Inc.
INDUSTRY VETERAN TO LEAD NEW CONTINUOUS GLUCOSE MONITORING R&D PROGRAM Rutherford, NJ, Oct. 14, 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a...
Nemaura Receives Provisional Purchase Order from Middle East Licensee TPMENA
12 oct. 2022 11h00 HE
|
Nemaura Medical, Inc
LOUGHBOROUGH, ENGLAND, Oct. 12, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and...